Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy for Glioblastoma: Current Progress and Challenges
Miranda W. Yu, Daniela F. Quail
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy
Jing Gao, Yuanzheng Liang, Liang Wang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 276
Glioblastoma Treatment: State-of-the-Art and Future Perspectives
Alejandro Rodríguez-Camacho, José Guillermo Flores-Vázquez, Júlia Moscardini-Martelli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7207-7207
Open Access | Times Cited: 81
Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma
Zhongzheng Sun, Yongquan Zhao, Wei Yan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 69
Advances in immunotherapy for glioblastoma multiforme
Ahmad Bakur Mahmoud, Reham Ajina, Sarah Aref, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 66
Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives
Uğur Sener, Michael W. Ruff, Jian L. Campian
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7046-7046
Open Access | Times Cited: 46
Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma
Hong Luo, Hao Zhang, Jinning Mao, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 40
From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancer
Estrella Gonzales‐Aloy, Aria Ahmed-Cox, Maria Tsoli, et al.
Advanced Drug Delivery Reviews (2023) Vol. 196, pp. 114777-114777
Closed Access | Times Cited: 28
Stimuli‐Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood‐to‐Brain Trafficking and Tumor Targeting
Cláudia Martins, Marco Araújo, Alessio Malfanti, et al.
Small (2023) Vol. 19, Iss. 22
Open Access | Times Cited: 26
Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches
Karol Sadowski, Adrianna Jażdżewska, Jan Kozłowski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5774-5774
Open Access | Times Cited: 16
Nanotechnology Meets Stem Cell Therapy for Treating Glioblastomas: A Review
Anup K. Ghosh, Aparajita Ghosh, Prasanta Kumar Das
ACS Applied Nano Materials (2024) Vol. 7, Iss. 3, pp. 2430-2460
Closed Access | Times Cited: 12
A systematic review of immunotherapy in high-grade glioma: learning from the past to shape future perspectives
Giacomo Sferruzza, Stefano Consoli, Fedele Dono, et al.
Neurological Sciences (2024) Vol. 45, Iss. 6, pp. 2561-2578
Closed Access | Times Cited: 9
The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies
Hamed Hosseinalizadeh, Mehrdad Mahmoodpour, Ali Akbar Samadani, et al.
Medical Oncology (2022) Vol. 39, Iss. 9
Open Access | Times Cited: 31
Investigating the causal impact of gut microbiota on glioblastoma: a bidirectional Mendelian randomization study
Chuan Zeng, Chaolong Zhang, Chunming He, et al.
BMC Genomics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 20
Recent Advances in Biomimetic Strategies for the Immunotherapy of Glioblastoma
Haoyu You, Shuo Geng, Shangkuo Li, et al.
Biomaterials (2024) Vol. 311, pp. 122694-122694
Closed Access | Times Cited: 8
Complement and coagulation cascades are associated with prognosis and the immune microenvironment of lower-grade glioma
Jianmei Yang, Lei Shen, Jingyi Yang, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 1, pp. 112-136
Open Access | Times Cited: 7
Lnc-H19-derived protein shapes the immunosuppressive microenvironment of glioblastoma
Junju Chen, Yixin Gao, Jian Zhong, et al.
Cell Reports Medicine (2024), pp. 101806-101806
Open Access | Times Cited: 6
Functional virus-specific memory T cells survey glioblastoma
Jianfang Ning, Noah Veis Gavil, Shaoping Wu, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 8, pp. 1863-1875
Open Access | Times Cited: 28
Molecular targeted therapy: A new avenue in glioblastoma treatment (Review)
Oula El Atat, Rayan Naser, Maya Abdelkhalek, et al.
Oncology Letters (2022) Vol. 25, Iss. 2
Open Access | Times Cited: 27
Targeting PP2A for cancer therapeutic modulation
Halle Ronk, Jared S. Rosenblum, Timothy Kung, et al.
Cancer Biology and Medicine (2022) Vol. 19, Iss. 10, pp. 1428-1439
Open Access | Times Cited: 25
Converging Mechanisms of Epileptogenesis and Their Insight in Glioblastoma
Kate E. Hills, Kostas Kostarelos, Robert C. Wykes
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 23
Combination of immune checkpoint inhibitors with radiation therapy in cancer: A hammer breaking the wall of resistance
Veronika Voronova, Anastasia Vislobokova, Kerim Mutig, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 23
Cellular senescence in glioma
Rafał Chojak, Jawad Fares, Edgar Petrosyan, et al.
Journal of Neuro-Oncology (2023) Vol. 164, Iss. 1, pp. 11-29
Closed Access | Times Cited: 16
Tumor-neutrophil crosstalk promotes in vitro and in vivo glioblastoma progression
Dominique S. Rubenich, Priscila Oliveira de Souza, Natália Omizzollo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Integration analysis of single-cell and spatial transcriptomics reveal the cellular heterogeneity landscape in glioblastoma and establish a polygenic risk model
Yaxuan Liu, Zhenyu Wu, Yueyuan Feng, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Photodynamic therapy and associated targeting methods for treatment of brain cancer
Dorota Bartusik‐Aebisher, Iga Serafin, Klaudia Dynarowicz, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top